Skip to main content
. 2010 Jun 18;95(11):1841–1848. doi: 10.3324/haematol.2010.026294

Figure 5.

Figure 5.

Hydroxycarbamide (HC) decreases the rate of RBC-PBMC aggregation in SS patients. Percentage of PBMC in aggregates in SS untreated patients (▪, n=17), HC-treated patients (▴, n=8) and AA subjects (▾, n=5). *P=0.013, **P=0.0186, Mann-Whitney test.